Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-11-03 Purchase |
2022-11-03 2:07 pm |
Merus N.V. | MRUS | Lundberg Sven Ante President, CEO & PFO |
14,706 | $14.38 | $211,431 | 78,071 (Indirect Direct) |
View |
| 2022-08-22 Purchase |
2022-08-23 4:09 pm |
Merus N.V. | MRUS | Lundberg Sven Ante President, CEO & PFO |
5,826 | $22.92 | $133,558 | 25,870 (Direct) |
View |
| 2022-08-19 Purchase |
2022-08-22 3:02 pm |
Merus N.V. | MRUS | Lundberg Sven Ante President, CEO & PFO |
704 | $22.99 | $16,187 | 20,044 (Direct) |
View |
| 2022-07-12 Purchase |
2022-07-13 10:13 am |
Merus N.V. | MRUS | Lundberg Sven Ante President, CEO & PFO |
4,340 | $22.97 | $99,685 | 19,340 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-02-24 Option Award |
2025-02-26 9:52 pm |
N/A 2028-12-06 |
Q32 Bio Inc. | QTTB | Lundberg Sven Ante Director |
70,178 | $0 | 70,178 (Direct) |
View |
| 2025-02-19 Gift |
2025-02-21 4:05 pm |
N/A N/A |
Merus N.V. | MRUS | Lundberg Sven Ante President, CEO & PEO |
40,601 | $0 | 40,601 (Direct) |
View |
| 2025-02-13 Exercise |
2025-02-18 5:43 pm |
N/A 2031-02-16 |
Merus N.V. | MRUS | Lundberg Sven Ante President, CEO & PEO |
16,372 | $0 | 392,229 (Direct) |
View |
| 2025-02-13 Exercise |
2025-02-18 5:43 pm |
N/A N/A |
Merus N.V. | MRUS | Lundberg Sven Ante President, CEO & PEO |
16,372 | $24.43 | 392,229 (Direct) |
View |
| 2025-01-29 Option Award |
2025-01-31 4:31 pm |
N/A 2035-01-29 |
Merus N.V. | MRUS | Lundberg Sven Ante President, CEO & PEO |
300,000 | $0 | 300,000 (Direct) |
View |
| 2024-09-25 Option Award |
2024-09-27 9:57 pm |
N/A 2034-09-24 |
Q32 Bio Inc. | QTTB | Lundberg Sven Ante Director |
1,316 | $0 | 1,316 (Direct) |
View |
| 2024-05-23 Option Award |
2024-05-28 4:10 pm |
N/A 2034-05-22 |
Vor Biopharma Inc. | VOR | Lundberg Sven Ante Director |
30,000 | $0 | 30,000 (Direct) |
View |
| 2024-05-07 Option Award |
2024-05-09 4:30 pm |
N/A 2034-01-31 |
Merus N.V. | MRUS | Lundberg Sven Ante President, CEO & PEO |
360,000 | $0 | 360,000 (Direct) |
View |
| 2024-03-25 Option Award |
2024-03-27 5:25 pm |
N/A 2034-03-24 |
Q32 Bio Inc. | QTTB | Lundberg Sven Ante Director |
12,767 | $0 | 12,767 (Direct) |
View |
Ownership |
2024-03-27 5:14 pm |
N/A N/A |
Q32 Bio Inc. | QTTB | Lundberg Sven Ante Director |
0 | $0 | 12,331 (Direct) |
View |
| 2023-05-26 Option Award |
2023-06-02 4:34 pm |
N/A 2033-05-25 |
Vor Biopharma Inc. | VOR | Lundberg Sven Ante Director |
30,000 | $0 | 30,000 (Direct) |
View |
| 2023-02-02 Option Award |
2023-02-03 4:23 pm |
N/A 2033-02-02 |
Merus N.V. | MRUS | Lundberg Sven Ante President, CEO & PFO |
380,000 | $0 | 380,000 (Direct) |
View |
| 2022-06-14 Option Award |
2022-06-16 5:07 pm |
N/A 2032-06-13 |
Vor Biopharma Inc. | VOR | Lundberg Sven Ante Director |
16,911 | $0 | 16,911 (Direct) |
View |
| 2022-01-31 Option Award |
2022-02-02 2:02 pm |
N/A 2032-01-31 |
Merus N.V. | MRUS | Lundberg Sven Ante President, CEO & PFO |
295,000 | $0 | 295,000 (Direct) |
View |
| 2021-08-02 Exercise |
2021-08-04 3:56 pm |
N/A 2029-03-19 |
Merus N.V. | MRUS | Lundberg Sven Ante President, CEO & PFO |
2,373 | $12.54 | 357,917 (Direct) |
View |
| 2021-08-02 Exercise |
2021-08-04 3:56 pm |
N/A 2030-01-03 |
Merus N.V. | MRUS | Lundberg Sven Ante President, CEO & PFO |
12,627 | $13.52 | 357,917 (Direct) |
View |
| 2021-03-25 Gift |
2021-03-29 7:18 pm |
N/A N/A |
Merus N.V. | MRUS | Lundberg Sven Ante President, CEO & PFO |
74,000 | $0 | 111,495 (Direct) |
View |
| 2021-03-01 Exercise |
2021-03-03 4:00 pm |
N/A 2029-03-19 |
Merus N.V. | MRUS | Lundberg Sven Ante President, CEO & PFO |
74,000 | $0 | 431,917 (Direct) |
View |
| 2021-03-01 Exercise |
2021-03-03 4:00 pm |
N/A N/A |
Merus N.V. | MRUS | Lundberg Sven Ante President, CEO & PFO |
10,830 | $12.54 | 431,917 (Direct) |
View |
| 2021-03-01 Exercise |
2021-03-03 4:00 pm |
N/A N/A |
Merus N.V. | MRUS | Lundberg Sven Ante President, CEO & PFO |
63,170 | $13.52 | 431,917 (Direct) |
View |
| 2021-02-16 Option Award |
2021-02-18 4:00 pm |
N/A 2031-02-16 |
Merus N.V. | MRUS | Lundberg Sven Ante President, CEO & PFO |
368,000 | $0 | 368,000 (Direct) |
View |
| 2021-02-05 Option Award |
2021-02-09 5:14 pm |
N/A 2031-02-04 |
Vor Biopharma Inc. | VOR | Lundberg Sven Ante Director |
16,900 | $0 | 16,900 (Direct) |
View |
Ownership |
2021-02-04 9:48 pm |
N/A N/A |
Vor Biopharma Inc. | VOR | Lundberg Sven Ante Director |
0 | $0 | 50,394 (Direct) |
View |